Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Results
Phase 2
This study looked at pembrolizumab and epacadostat as a first treatment for non small cell lung cancer that had spread.
People could join the study between February and July 2018. The team published the results in 2024.
There is a link to more information in the ‘Summary of results’ section below.
Recruitment start: 7 February 2018
Recruitment end: 31 July 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Katy Clarke
Merck Sharp & Dohme Ltd
Last reviewed: 16 Jul 2026
CRUK internal database number: 15426
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
